Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856043) titled '[11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Stony Brook University

Condition: Heart Failure With Reduced Ejection Fraction Cognitive Impairment, Mild Neuroinflammation Vascular Contributions to Cognitive Impairment and Dementia (VCID)

Intervention: Drug: [11C]PS13: [carbon-11]PS13 COX-1 PET radioligand

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollmen...